Agilent Technologies, Inc. (A)
Automate Your Wheel Strategy on A
With Tiblio's Option Bot, you can configure your own wheel strategy including A - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol A
- Rev/Share 24.5512
- Book/Share 23.8198
- PB 5.5475
- Debt/Equity 0.4976
- CurrentRatio 1.9574
- ROIC 0.1257
- MktCap 37461744970.0
- FreeCF/Share 4.0707
- PFCF 32.5189
- PE 28.6996
- Debt/Assets 0.2635
- DivYield 0.0076
- ROE 0.2062
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 3
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | A | HSBC Securities | -- | Buy | -- | $180 | Jan. 20, 2026 |
| Upgrade | A | Evercore ISI | In-line | Outperform | -- | $160 | Jan. 5, 2026 |
| Upgrade | A | Barclays | Equal Weight | Overweight | -- | $165 | Dec. 15, 2025 |
| Initiation | A | Goldman | -- | Buy | -- | $170 | Dec. 9, 2025 |
| Initiation | A | Morgan Stanley | -- | Overweight | -- | $270 | Dec. 2, 2025 |
| Upgrade | A | UBS | Neutral | Buy | -- | $170 | Oct. 8, 2025 |
| Initiation | A | Rothschild & Co Redburn | -- | Buy | -- | $165 | Oct. 8, 2025 |
| Upgrade | A | Barclays | Underweight | Equal Weight | $135 | $145 | Feb. 10, 2025 |
| Initiation | A | Wells Fargo | -- | Overweight | -- | $157 | Aug. 28, 2024 |
News
PBH vs. A: Which Stock Is the Better Value Option?
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Published: January 13, 2026 by: Seeking Alpha
Sentiment: Neutral
Agilent Technologies, Inc. (A) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Read More
Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Published: December 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Read More
Agilent (A) International Revenue Performance Explored
Published: December 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Read More
5 Stocks Worth Watching on Recent Dividend Hikes
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
A group of dividend raisers OBT, UBSI, DDS, PATK and A stand out as investors seek stability amid volatile markets, rate-cut hopes and mixed economic signals.
Read More
Agilent Technologies: Steady As She Goes
Published: November 26, 2025 by: Seeking Alpha
Sentiment: Positive
Agilent Technologies delivered strong Q4 2025 results, with revenue and EPS beating expectations and robust growth in Life Sciences and Diagnostics segment. Management forecasts FY26 revenue growth of 6% and normalized EPS between $5.86 and $6.00, signaling continued solid performance. Agilent now trades at a 6% premium to fair value after a 23% rally, outpacing the S&P 500 handily since my August coverage.
Read More
Agilent Q4 Earnings Match Estimates, Revenues Up Y/Y, Shares Fall
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
A report higher Q4 revenues and lifts its 2026 outlook, yet the stock slips as margins narrow across key business segments.
Read More
Agilent (A) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: November 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Beyond analysts' top-and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2025.
Read More
Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening
Published: September 30, 2025 by: Business Wire
Sentiment: Neutral
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of its new Insight Series Alarm Resolution Systems, designed to enhance safety and streamline operations at airport security checkpoints worldwide. The Insight Series includes the Insight300M and InsightBLS, advanced liquid explosive detection systems (LEDs) that meet global regulations for screening liquids, aerosols, and gels (LAGs). With the industry's lowest false alarm rate and rapid scan t.
Read More
Agilent Technologies, Inc. (A) gilent Technologies, Inc. Presents at Bank of merica Global Healthcare Conference 2025 Transcript
Published: September 25, 2025 by: Seeking Alpha
Sentiment: Neutral
Agilent Technologies, Inc. (NYSE:A ) gilent Technologies, Inc. Bank of merica Global Healthcare Conference 2025 September 25, 2025 4:50 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Conference Call Participants Michael Ryskin - BofA Securities, Research Division Presentation Michael Ryskin BofA Securities, Research Division I'm Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team based in New York.
Read More
GEHC or A: Which Is the Better Value Stock Right Now?
Published: September 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
GEHC or A: Which Is the Better Value Stock Right Now?
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Agilent Technologies (A). But which of these two stocks is more attractive to value investors?
Read More
Why Agilent (A) International Revenue Trends Deserve Your Attention
Published: September 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Evaluate Agilent's (A) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Read More
Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
A posts fiscal Q3 earnings and revenue beats, with double-digit sales growth and upbeat guidance lifting shares.
Read More
Unveiling Agilent (A) Q3 Outlook: Wall Street Estimates for Key Metrics
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Agilent (A), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
Read More
GEHC or A: Which Is the Better Value Stock Right Now?
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical - Products sector might want to consider either GE HealthCare Technologies (GEHC) or Agilent Technologies (A). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says
Published: July 29, 2025 by: Reuters
Sentiment: Positive
U.S.-based laboratory equipment maker Agilent Technologies plans to double its investments in India to expand in one of its fastest-growing markets, a top executive said.
Read More
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Read More
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Published: June 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Agilent Technologies, Inc. (NYSE:A ) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior VP & CFO Conference Call Participants Tycho W.
Read More
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Neutral
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Read More
Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Neutral
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
Read More
Curious about Agilent (A) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.
Read More
Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors
Published: May 21, 2025 by: Business Wire
Sentiment: Neutral
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been elected to its Board of Directors, effective May 21, 2025. Soriot and Gawlik Brown bring decades of global leadership experience across the pharmaceutical, biotechnology, and health-care sectors, with proven track records in strategy, innovation, operations, and finance. Pascal Soriot has led Astr.
Read More
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto
Published: April 24, 2025 by: Seeking Alpha
Sentiment: Positive
City Office REIT's Series A Preferred Shares offer a tempting yield despite recent accounting losses and systemic pressures, suggesting a potential buying opportunity. The shares are cumulative, redeemable, and fixed, ensuring eventual dividend payments, though call risk and financial restructuring are potential concerns. The REIT's fundamentals, including an 85.8% occupancy rate and sector diversification, support sustainability, with positive economic profitability and AFFO figures.
Read More
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today
Published: April 03, 2025 by: Seeking Alpha
Sentiment: Positive
Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-time economic indicators show GDP growth of more than 2%, despite widespread recession fears, highlighting a disconnect between sentiment and fundamentals. Inflation truth vs. hype: Real-time data shows inflation is falling, contradicting consumer fears and demonstrating that stagflation panic may be premature.
Read More
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Published: March 24, 2025 by: Business Wire
Sentiment: Neutral
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) is pleased to announce its role in supporting Autolus Therapeutics' FDA approval for AUCATZYL®, a recently approved CAR T therapy. Agilent's advanced cell analysis instrumentation, specifically the xCELLigence Real-Time Cell Analysis (RTCA) technology, was applied in developing and validating AUCATZYL. The xCELLigence RTCA technology supported the development and implementation of the potency assay. By providing precise a.
Read More
CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
Published: March 20, 2025 by: Business Wire
Sentiment: Neutral
SANTA CLARA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the fifth paragraph. The updated release reads: AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025 Agilent Technologies Inc. (NYSE: A) is excited to announce its participation at the upcoming United States and Canadian Academy of Pathology (USCAP) Conference, which will be held March 22-27, 2025, in Boston. At the conference, Agilent will.
Read More
Unlocking Agilent (A) International Revenues: Trends, Surprises, and Prospects
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Read More
About Agilent Technologies, Inc. (A)
- IPO Date 1999-11-18
- Website https://www.agilent.com
- Industry Medical - Diagnostics & Research
- CEO Padraig McDonnell
- Employees 17900